Evidence map›Paper›PMID 31249789›Full record

ArticleToxicology reports2019

Anticancer effect of fucoidan on cell proliferation, cell cycle progression, genetic damage and apoptotic cell death in HepG2 cancer cells.

Arumugam P, Arunkumar K, Sivakumar L, Murugan M, Murugan K

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Anticancer Activity ofBiomolecules · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Pro-Apoptotic Activity and Cell Cycle Arrest ofMolecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Investigation and Biological Assessment ofMolecules (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Fucoidan and Alginate from the Brown AlgaeMolecules (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Antitumor effect and molecular mechanism of fucoidan in NSCLC.BMC complementary medicine and therapies · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Sturgeon (Nutrients · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Arumugam PDepartment of Zoology, School of Life Science, Bharathiar University, Coimbatore, 641 046, Tamil Nadu, India.
Arunkumar KDepartment of Plant Science, School of Biological Sciences, Central University of Kerala, Riverside Transit Campus, Padanakkad, 671 314, Kasaragod, Kerala, India.
Sivakumar LDepartment of Environmental Science, Periyar University, Salem, 636011, Tamil Nadu, India.
Murugan MDepartment of Microbial Technology, School of Biological Science, Madurai Kamaraj University, Madurai, 625 021, Tamil Nadu, India.
Murugan KDepartment of Zoology, School of Life Science, Bharathiar University, Coimbatore, 641 046, Tamil Nadu, India.
Bharathiar University · INCentral University of Kerala · INMadurai Kamaraj University · INPeriyar University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The centre of the attraction of this article is inevitably associated with fucoidan polymers in terms of brown seaweed such as

Indexed as

ApoptosisCell cycleFucoidanGenetic damageHepG2 cellsNatural biopolymerSeaweed

Identifiers

PMID31249789
PMCPMC6587026
OpenAlexW2949556875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.